A recent panel concluded, “The current methods for defining AKI using routinely collected data are inconsistent and poorly described in the available literature.” Learn more about their recommendations for establishing consensus definitions and practices for AKI data analysis.
Regulatory Efforts to Support Judicious Use of Antimicrobials in the Agricultural Industry
Learn more about practices that can help protect animal health, farm employees, and our communities, as well as how the FDA and other agencies are working to promote judicious use of antibiotics
What You Can Expect from the New National Action Plan for Combating Antibiotic-Resistant Bacteria
In a continued effort to fight AMR, the Federal Task Force on Combating Antibiotic-Resistant Bacteria (CARB) released the 2020-2025 National Action Plan for CARB in October 2020.
What Happened to My Baseline? Evidence-Based Care in the COVID-19 Era
“Baselines are used throughout healthcare to evaluate safety, performance, and fiscal execution at the macro and micro level,” writes John Hurst, Pharm D, BCIDP and Senior Director of Antimicrobial Stewardship at bioMérieux.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...